The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death
Abstract
Regulated glycosylation controls T cell processes, including activation, differentiation and homing by creating or masking ligands for endogenous lectins. Here we show that stimuli promoting T helper type 1 (TH1), TH2 or interleukin 17-producing T helper (TH-17) differentiation can differentially regulate the glycosylation pattern of T helper cells and modulate their susceptibility to galectin-1, a glycan-binding protein with anti-inflammatory activity. Although TH1- and TH-17-differentiated cells expressed the repertoire of cell surface glycans critical for galectin-1-induced cell death, TH2 cells were protected from galectin-1 through differential sialylation of cell surface glycoproteins. Consistent with those findings, galectin-1-deficient mice developed greater TH1 and TH-17 responses and enhanced susceptibility to autoimmune neuroinflammation. Our findings identify a molecular link among differential glycosylation of T helper cells, susceptibility to cell death and termination of the inflammatory response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, the glycosylation state of some death receptors (e.g., FAS) has been shown to impact on the sensitivity of T lymphocytes to extrinsic apoptosis, hence influencing the termination of inflammatory responses [288–290].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [288]
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
Zhu, C., Anderson, A. C., Schubart, A., Xiong, H., Imitola, J., Khoury, S. J., Zheng, X. X., Strom, T. B., & Kuchroo, V. K. (2005) · Nature Immunology · doi:10.1038/ni1271 · Cited by 2,057
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
TH-17 cells in the circle of immunity and autoimmunity
Bettelli, E., Oukka, M., & Kuchroo, V. K. (2007) · Nature Immunology · doi:10.1038/ni0407-345 · Cited by 1,520
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., Blank, R. B., Meylan, F., Siegel, R., Hennighausen, L., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.02.009 · Cited by 1,507
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 648
Tumor-derived factors affecting immune cells
Russo, V. E. A., & Protti, M. P. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.005 · Cited by 33
Galectin-3 Regulates γ-Herpesvirus Specific CD8 T Cell Immunity
Kaur, M., Kumar, D., Butty, V. L., Singh, S., Esteban, A., Fink, G. R., Ploegh, H. L., & Sehrawat, S. (2018) · iScience · doi:10.1016/j.isci.2018.10.013 · Cited by 33
Ilarregui, J. M., & Rabinovich, G. A. (2010) · NeuroImmunoModulation · doi:10.1159/000258712 · Cited by 32
Self-citationThorborn, G., Pomeroy, L., Isohanni, H., Perry, M., Peters, B. S., & Vyakarnam, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009254 · Cited by 32
Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cells
Nishida, A., Nagahama, K., Imaeda, H., Ogawa, A., Lau, C. W., Kobayashi, T., Hisamatsu, T., Preffer, F. I., Mizoguchi, E., Ikeuchi, H., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112631 · Cited by 32
Glycans as critical regulators of gut immunity in homeostasis and disease
Dias, A. M., Pereira, M. S., Padrão, N., Alves, I., Marcos‐Pinto, R., Lago, P., & Pinho, S. S. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.007 · Cited by 35
Novel role for galectin-1 in T-cells under physiological and pathological conditions
Deák, M., Hornung, Á., Novák, J., Demydenko, D., Szabó, E. V., Czibula, Á., Fajka‐Boja, R., Kriston-Pál, É., Monostori, É., & Kovács, L. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.10.023 · Cited by 31
Parco, I. E.-L., Gendronneau, G., Dang, T., Delacour, D., Thijssen, V. L., Edelmann, W., Peuchmaur, M. M., & Poirier, F. (2008) · Glycobiology · doi:10.1093/glycob/cwn105 · Cited by 31
Self-citationFermino, M. L., Dergan‐Dylon, L. S., Cecílio, N. T., dos Santos, S. N., Toscano, M. A., Dias‐Baruffi, M., Roque‐Barreira, M. C., Rabinovich, G. A., & Bernardes, E. S. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.06.005 · Cited by 31
Self-citationSzabó, E. V., Hornung, Á., Monostori, É., Bocskai, M., Czibula, Á., & Kovács, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184455 · Cited by 31
Roles of galectin‑3 in the tumor microenvironment and tumor metabolism (Review)
Guo, Y., Shen, R., Yu, L., Zheng, X., Cui, R., Song, Y., & Wang, D. (2020) · Oncology Reports · doi:10.3892/or.2020.7777 · Cited by 31
Guardia, C. M. A., Gauto, D. F., Lella, S. D., Rabinovich, G. A., Marti, M. A., & Estrin, D. A. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200180h · Cited by 31
Self-citationSaravanan, C., Cao, Z., Head, S. R., & Panjwani, N. (2009) · Glycobiology · doi:10.1093/glycob/cwp133 · Cited by 31
Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
Corapi, E., Carrizo, G., Compagno, D., & Laderach, D. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02190 · Cited by 31
Zhang, Y., Han, J., Wu, M., Xu, L., Wang, Y., Yuan, W., Hua, F., Fan, H., Dong, F., Qu, X., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09854-1 · Cited by 30
Mendoza, M., Lu, D., Ballesteros, Á., Blois, S. M., Abernathy, K., Feng, C., Dimitroff, C. J., Zmuda, J. F., Panico, M., Dell, A., et al. (2020) · Glycobiology · doi:10.1093/glycob/cwaa034 · Cited by 30
Morosi, L. G., Cutine, A. M., Cagnoni, A. J., Cocco, M. N. M., Croci, D. O., Merlo, J. P., Morales, R. M., May, M., Pérez‐Sáez, J. M., Girotti, M. R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf8630 · Cited by 30
Self-citationGALNT11 as a new molecular marker in chronic lymphocytic leukemia
Libisch, G., Casás, M., Chiribao, M., Moreno, P., Cayota, A., Osinaga, E., Oppezzo, P., & Robello, C. (2013) · Gene · doi:10.1016/j.gene.2013.09.052 · Cited by 30
Long, E., Baker, S., Oliveira, V. G., Sawitzki, B., & Wood, K. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008894 · Cited by 30
Glycoimmunology: ignore at your peril!
Baum, L. G., & Crocker, P. R. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00800.x · Cited by 30
Self-citationRegulatory T Cells in Colorectal Cancer: From Biology to Prognostic Relevance
Mougiakakos, D. (2011) · Cancers · doi:10.3390/cancers3021708 · Cited by 30
Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation
Lyadova, I. V., Sosunova, E., Николаев, А. А., & Nenasheva, T. A. (2016) · Journal of Immunology Research · doi:10.1155/2016/7121580 · Cited by 30
Differential Cellular Expression of Galectin-1 and Galectin-3 After Intracerebral Hemorrhage
Bonsack, F., & Sukumari‐Ramesh, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00157 · Cited by 32
Borowski, S., Tirado‐González, I., Freitag, N., García, M. G., Barrientos, G., & Blois, S. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01316 · Cited by 30
Cheng, S., Xiao, B., & Luo, Z. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00506-4 · Cited by 31
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
Videla-Richardson, G. A., Morris-Hanon, O., Torres, N. I., Esquivel, M. I., Vera, M. B., Ripari, L. B., Croci, D. O., Sevlever, G. E., & Rabinovich, G. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010316 · Cited by 29
Self-citationTherapeutic potential of targeting galectins – A biomaterials-focused perspective
Martín‐Saldaña, S., Chevalier, M. T., & Pandit, A. S. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121585 · Cited by 32
Lau, L. S., Mohammed, N. B. B., & Dimitroff, C. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415554 · Cited by 29
Inflammation and skeletal metastasis
Roca, H., & McCauley, L. K. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.75 · Cited by 29
Huang, H., Chen, C., Lin, C., Wong, C., & Lin, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309417110 · Cited by 29
Sweet role of platelet endothelial cell adhesion molecule in understanding angiogenesis
Kitazume, S., Imamaki, R., Ogawa, K., & Taniguchi, N. (2014) · Glycobiology · doi:10.1093/glycob/cwu094 · Cited by 29
Glyco‐biomarkers: Potential Determinants of Cellular Physiology and Pathology
Alavi, A., & Axford, J. S. (2008) · Disease Markers · doi:10.1155/2008/863032 · Cited by 29
Pelka, M. A., Trautmann, S., Petschelt, A., & Lohbauer, U. (2010) · PubMed · Cited by 29
Glucose-dependent glycosphingolipid biosynthesis fuels CD8+ T cell function and tumor control
Longo, J., DeCamp, L. M., Oswald, B. M., Teis, R., Reyes-Oliveras, A., Dahabieh, M. S., Ellis, A. E., Vincent, M. P., Damico, H., Gallik, K. L., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.07.006 · Cited by 30
SundarRaj, S., Soni, C., & Karande, A. A. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.07.013 · Cited by 28
Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis
Colomb, F., Giron, L. B., Trbojević‐Akmačić, I., Lauc, G., & Abdel‐Mohsen, M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00433-w · Cited by 28
Luo, Z., Ji, Y., Tian, D., Zhang, Y., Chang, S., Yang, C., Zhou, H., & Chen, Z. K. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.003 · Cited by 28
Galectins in the Tumor Microenvironment: Focus on Galectin-1
Martínez‐Bosch, N., & Navarro, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_2 · Cited by 27
Tiraboschi, C., Gentilini, L. D., Velazquez, C., Corapi, E., Jaworski, F. M., Garcia, J. D. G., Rondón, Y., Chauchereau, A., Laderach, D. J., & Compagno, D. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001535 · Cited by 27
Sweet Immune Checkpoint Targets to Enhance T Cell Therapy
Derosiers, N., Aguilar, W., Degaramo, D. A., & Posey, A. D. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100706 · Cited by 27
Reduced expression of galectin-1 and galectin-9 by leucocytes in asthma patients
Sánchez-Cuéllar, S., de la Fuente, H., Cruz‐Adalia, A., Lamana, A., Cibrián, D., Girón, R. M., Vara, A., Sánchez‐Madrid, F., & Ancochea, J. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04665.x · Cited by 27
Analytical Tools for the Study of Cellular Glycosylation in the Immune System
van Kooyk, Y., Kalay, H., & García-Vallejo, J. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00451 · Cited by 27
Immune response modulation by Galectin-1 in a transgenic model of neuroblastoma
Büchel, G., Schulte, J. H., Harrison, L., Batzke, K., Schüller, U., Hansen, W., & Schramm, A. R. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1131378 · Cited by 29
Pang, M., He, J., Johnson, P., & Baum, L. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804329 · Cited by 28
Self-citationDC expressing transgene Foxp3 are regulatory APC
Lipscomb, M. W., Taylor, J. L., Goldbach, C., Watkins, S. C., Wesa, A. K., & Storkus, W. J. (2009) · European Journal of Immunology · doi:10.1002/eji.200939667 · Cited by 27
Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer
Funk-Hilsdorf, T. C., Behrens, F., Grune, J., & Simmons, S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.819145 · Cited by 28
Manipulating Cell Surface Glycoproteins by Targeting N-Glycan–Galectin Interactions
Grigorian, A., & Demetriou, M. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)80012-6 · Cited by 26
Integration of lectin–glycan recognition systems and immune cell networks in CNS inflammation
Méndez‐Huergo, S. P., Maller, S. M., Farez, M., Mariño, K. V., Correale, J. D., & Rabinovich, G. A. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.02.003 · Cited by 26
Self-citationTumor Immune Escape Mechanisms that Operate During Metastasis
Croci, D. O., & Salatino, M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798376987 · Cited by 26
Self-citationMalheiros, D., Panepucci, R. A., Roselino, A. M. F., Araújo, A. G., Zago, M. A., & Petzl‐Erler, M. L. (2014) · Immunology · doi:10.1111/imm.12315 · Cited by 26
Chen, J., Huang, H.-H., Yu, S., Wu, S., Kannagi, R., & Khoo, K. (2017) · Glycobiology · doi:10.1093/glycob/cwx091 · Cited by 26
Elevated Galectin-10 Expression of IL-22-Producing T Cells in Patients with Atopic Dermatitis
Noh, S., Jin, S., Park, C. O., Lee, Y. S., Lee, N., Lee, J., Shin, J. U., Kim, S. H., Yun, K. N., Kim, J. Y., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.369 · Cited by 26
Novák, J., Takács, T., Tilajka, Á., László, L., Oravecz, O., Farkas, E., Than, N. G., Buday, L., Balogh, A., & Vas, V. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-025-01047-8 · Cited by 27
Mari, E. R., Rasouli, J., Ćirić, B., Moore, J. N., Conejo-Garcia, J. R., Rajasagi, N. K., Zhang, G., Rabinovich, G. A., & Rostami, A. M. (2016) · European Journal of Immunology · doi:10.1002/eji.201546212 · Cited by 25
Self-citationGórniak, P., Wasylecka, M., Lugowska, I. A., Rutkowski, P. L., Polak, A., Szydłowski, M., & Juszczyński, P. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12695 · Cited by 26
Park, D., Chen, J., Kudelka, M. R., Jia, N., Haller, C. A., Kosaraju, R. S., Premji, A., Galizzi, M., Nairn, A. V., Moremen, K. W., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.12.005 · Cited by 25
Tissue-specific control of galectin-1-driven circuits during inflammatory responses
Cutine, A. M., Bach, C. A., Veigas, F., Merlo, J. P., Laporte, L., Cocco, M. N. M., Massaro, M., Sarbia, N., Perrotta, R. M., Mahmoud, Y. D., et al. (2021) · Glycobiology · doi:10.1093/glycob/cwab007 · Cited by 28
Self-citationMedawar’s PostEra: Galectins Emerged as Key Players During Fetal-Maternal Glycoimmune Adaptation
Menkhorst, E. M., Than, N. G., Jeschke, U., Barrientos, G., Szereday, L., Dveksler, G. S., & Blois, S. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.784473 · Cited by 26
Mascanfroni, I. D., Cerliani, J. P., Dergan‐Dylon, S., Croci, D. O., Ilarregui, J. M., & Rabinovich, G. A. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.021 · Cited by 27
Self-citationSartim, M. A., Riul, T. B., Andrade, C. D. C., Stowell, S. R., Arthur, C. M., Sorgi, C. A., Faccioli, L. H., Cummings, R. D., Dias‐Baruffi, M., & Sampaio, S. V. (2014) · Glycobiology · doi:10.1093/glycob/cwu061 · Cited by 25
Öberg, C. T., Noresson, A., Leffler, H., & Nilsson, U. J. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201003247 · Cited by 25
Galectin-1 and immunotherapy for brain cancer
Verschuere, T., Vleeschouwer, S. D., Lefranc, F., Robert Kiss, A., & Gool, S. V. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.40 · Cited by 25
Critical Role of the Solvent Environment in Galectin-1 Binding to the Disaccharide Lactose
Lella, S. D., Ma, L., Ricci, J. C. D., Rabinovich, G. A., Asher, S. A., & Álvarez, R. M. S. (2009) · Biochemistry · doi:10.1021/bi801855g · Cited by 25
Self-citationBosticardo, M., Dobbs, K., Delmonte, O. M., Martins, A. J., Pala, F., Kawai, T., Kenney, H., Magro, G., Rosen, L. B., Yamazaki, Y., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adq1697 · Cited by 26
Galectin-1 is a local but not systemic immunomodulatory factor in mesenchymal stromal cells
Fajka‐Boja, R., Urbán, V. S., Szebeni, G. J., Czibula, Á., Blaskó, A., Kriston-Pál, É., Makra, I., Hornung, Á., Szabó, E. V., Uher, F., et al. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2015.12.004 · Cited by 24
Engineering galectin–glycan interactions for immunotherapy and immunomodulation
Farhadi, S. A., & Hudalla, G. A. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216650055 · Cited by 24
Gómez‐Chávez, F., Castro‐Leyva, V., Espejel-Núñez, A., Zamora-Mendoza, R. G., Rosas‐Vargas, H., Cancino‐Díaz, J. C., Cancino-Diaz, M. E., Estrada‐Gutiérrez, G., & Rodríguez–Martínez, S. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.07.002 · Cited by 24
Chung, H., Gyu-mi, P., Na, Y. R., Lee, Y., Choi, H., & Seok, S. H. (2024) · Theranostics · doi:10.7150/thno.88917 · Cited by 24
Inflammation Controls Sensitivity of Human and Mouse Intestinal Epithelial Cells to Galectin-1
Muglia, C. I., Gobbi, R. P., Smaldini, P., Delgado, M. L. O., Candia, M., Zanuzzi, C. N., Sambuelli, A. M., Rocca, A., Toscano, M. A., Rabinovich, G. A., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25249 · Cited by 23
Self-citationChawla, S., Warren, T. A., Wockner, L. F., Lambie, D., Brown, I., Martin, T. P. C., Khanna, R., Leggatt, G. R., & Panizza, B. J. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1788-z · Cited by 23
Fine-Tuning Antitumor Responses Through the Control of Galectin–Glycan Interactions: An Overview
Salatino, M., & Rabinovich, G. A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-869-0_23 · Cited by 23
Self-citationOkumu, L. A., Fair, T., Szekeres‐Barthó, J., O’Doherty, A., Crowe, M. A., Roche, J. F., Lonergan, P., & Forde, N. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00251.2010 · Cited by 23
Possible novel biomarkers of organ involvement in systemic lupus erythematosus
Su, D., Liu, R., Li, X., & Sun, L. (2014) · Clinical Rheumatology · doi:10.1007/s10067-014-2560-z · Cited by 22
Andersen, M. N., Ludvigsen, M., Abildgaard, N., Petruskevicius, I., Hjortebjerg, R., Bjerre, M., Honoré, B., Møller, H. J., & Andersen, N. F. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s124321 · Cited by 22
Role of galectin-glycan circuits in reproduction: from healthy pregnancy to preterm birth (PTB)
Blois, S. M., Verlohren, S., Wu, G., Clark, G. F., Dell, A., Haslam, S. M., & Barrientos, G. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00801-4 · Cited by 22
Validation of galectin-1 as potential diagnostic biomarker of early rheumatoid arthritis
Triguero‐Martínez, A., de la Fuente, H., Montes, N. G., Ortiz, A. M., Roy‐Vallejo, E., Castañeda, S., González‐Álvaro, I., & Lamana, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-74185-8 · Cited by 22
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure
Laderach, D. J., & Compagno, D. (2021) · Cancers · doi:10.3390/cancers13184529 · Cited by 22
Luo, C., Luo, F., Man, X., Liu, X., Zhao, L., Che, L., Zhang, W., Guo, J., Cai, S., Wang, D., et al. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220511151343 · Cited by 22
Yu, W., Zhao, X., Jalloh, A. S., Li, Y., Zhao, Y., Dinner, B., Yang, Y., Ouyang, S., Tian, T., Zhao, Z., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c02602 · Cited by 21
Galectokines: The Promiscuous Relationship between Galectins and Cytokines
Sanjurjo, L., Broekhuizen, E. C., Koenen, R. R., & Thijssen, V. L. (2022) · Biomolecules · doi:10.3390/biom12091286 · Cited by 21
Redox state influence on human galectin-1 function
Yu, X., Scott, S. A., Pritchard, R., Houston, T. A., Ralph, S. J., & Blanchard, H. (2015) · Biochimie · doi:10.1016/j.biochi.2015.06.013 · Cited by 21
Targeting of T/Tn Antigens with a Plant Lectin to Kill Human Leukemia Cells by Photochemotherapy
Poiroux, G., Pitié, M., Culerrier, R. M., Lafont, É., Ségui, B., Damme, E. J. M. V., Peumans, W. J., Bernadou, J., Levade, T., Rougé, P., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023315 · Cited by 21
Galectin-1 Markedly Reduces the Incidence of Resorptions in Mice Missing Immunophilin FKBP52
Hirota, Y., Burnum-Johnson, K., Acar, N., Rabinovich, G. A., Daikoku, T., & Dey, S. K. (2012) · Endocrinology · doi:10.1210/en.2012-1035 · Cited by 21
Self-citationGalectins as therapeutic targets for hematological malignancies: a hopeful sweetness.
Peña, C., Mirandola, L., Figueroa, J. A., Hosiriluck, N., Suvorava, N., Trotter, K., Reidy, A., Rakhshanda, R., Payne, D., Jenkins, M., et al. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2014.09.14 · Cited by 21
Immunological tolerance induced by galectin-1 in rat allogeneic renal transplantation
Xu, G., Tu, W., & Xu, C. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.03.001 · Cited by 21
Villanueva-Cabello, T. M., Mollicone, R., Muñoz, M. E. C., López-Guerrero, D. V., & Martínez-Duncker, I. (2015) · Glycobiology · doi:10.1093/glycob/cwv062 · Cited by 21
Belief and contextual acceptance
Cresto, E. (2009) · Synthese · doi:10.1007/s11229-009-9637-2 · Cited by 20
Glycosylation of solute carriers: mechanisms and functional consequences
Borbye‐Lorenzen, N., Carlsson, M. C., & Pedersen, S. F. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-015-1730-4 · Cited by 21
Leskelä, S., Serrano, A. M., de la Fuente, H., Rodríguez‐Muñoz, A., Ramos-Levi, A. M., Sampedro-Nuñez, M. A., Sánchez‐Madrid, F., González‐Amaro, R., & Marazuela, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123938 · Cited by 20
Muglia, C. I., Mercer, N., Toscano, M. A., Schattner, M. A., Pozner, R., Cerliani, J. P., Gobbi, R. P., Rabinovich, G. A., & Docena, G. H. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.44 · Cited by 20
Self-citationCD43 – One molecule, many tales to recount
Pedraza‐Alva, G., & Rosenstein, Y. (2007) · Signal Transduction · doi:10.1002/sita.200700140 · Cited by 20
Zhao, Y., Wei, A., Zhang, H., Chen, X., Wang, L., Zhang, H., Yu, X., Yuan, Q., Zhang, J., & Wang, S. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.40 · Cited by 20
RetractedGalectin-1 and platelet factor 4 (CXCL4) induce complementary platelet responses in vitro
Dickhout, A., Tullemans, B. M. E., Heemskerk, J. W. M., Thijssen, V. L., Kuijpers, M. J. E., & Koenen, R. R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244736 · Cited by 20
Lella, S. D., Marti, M. A., Croci, D. O., Guardia, C. M. A., Ricci, J. C. D., Rabinovich, G. A., Caramelo, J. J., & Estrin, D. A. (2010) · Biochemistry · doi:10.1021/bi100356g · Cited by 19
Self-citationRamos-Martínez, I. E., Loustalot, P. M., Lozano, L., Issad, T., Limón, I. D., Díaz, A., Pérez‐Torres, A., Guevara, J., & Zenteno, E. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.11.008 · Cited by 19
Galectin-1 Expression in CD8+ T Lymphocytes Controls Inflammation in Contact Hypersensitivity
Castillo‐González, R., Cibrián, D., Fernández‐Gallego, N., Ramírez‐Huesca, M., Sáiz, M. L., Navarro, M. N., Fresno, M., de la Fuente, H., & Sánchez‐Madrid, F. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.10.020 · Cited by 19
Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases
Bordron, A., Morel, M., Bagacean, C., Dueymes, M., Pochard, P., Harduin‐Lepers, A., Jamin, C., & Pers, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073402 · Cited by 19
Dabelić, S., Novak, R., Goreta, S. Š., & Dumić, J. (2012) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-012-9540-x · Cited by 19
A chimeric, multivalent assembly of galectin-1 and galectin-3 with enhanced extracellular activity
Fettis, M. M., Farhadi, S. A., & Hudalla, G. A. (2019) · Biomaterials Science · doi:10.1039/c8bm01631c · Cited by 19
ABO blood groups and galectins: Implications in transfusion medicine and innate immunity
Arthur, C. M., Hollenhorst, M. A., Wu, S., Jajosky, R. P., Nakahara, H., Jan, H.-M., Zheng, L., Covington, M. L., Rakoff-Nahoum, S., Yeung, M. Y., et al. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101892 · Cited by 18
Metadata
- Authors
- Toscano, M. A., Bianco, G. A., Ilarregui, J. M., Croci, D. O., Correale, J., Hernandez, J. D., Zwirner, N. W., Poirier, F., Riley, E. M., Baum, L. G., & Rabinovich, G. A.
- Affiliations
- Universidad de Buenos Aires (AR)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- University of California, Los Angeles (US)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Rabinovich, Gabriel A
- ORCID
- Venue
- Nature Immunology
- Published
- 2007-06-24
- Volume
- 8
- Issue
- 8
- Pages
- 825-834
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2041659209
- Cited by
- 653
- References
- 52
- Citations by year
- 2026: 22 · 2025: 28 · 2024: 22 · 2023: 22 · 2022: 46 · 2021: 31 · 2020: 35 · 2019: 20 · 2018: 36 · 2017: 25 · 2016: 33 · 2015: 36 · 2014: 37 · 2013: 34 · 2012: 40
- FWCI
- 18.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Immunology and Microbiology › Immunology › Galectins and Cancer Biology
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- galectin-1, T helper cell differentiation, Th1 cells, Th2 cells, Th17 cells, sialylation, cell death, cell surface glycans, lectin binding, autoimmune neuroinflammation
- MeSH terms
- Animals, Cell Differentiation, Encephalomyelitis, Autoimmune, Experimental, Flow Cytometry, Glycosylation, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Membrane Glycoproteins, Polysaccharides, Immunoblotting, T-Lymphocyte Subsets, Apoptosis, Th1 Cells, Th2 Cells, Adoptive Transfer, In Situ Nick-End Labeling, Interleukin-17, Galectin 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review